Beyond troponin: emerging biomarker strategies to differentiate type 1 from type 2 myocardial infarction [0.03%]
超越肌钙蛋白：区分Ⅰ型和Ⅱ型心梗的新兴生物标志物策略
Silvio Saraullo,Andrea Palermi,Fabrizio Ricci et al.
Silvio Saraullo et al.
The widespread adoption of high-sensitivity cardiac troponin (hs-cTn) assays has markedly improved the detection of myocardial injury, but at the cost of reduced specificity for atherothrombotic type 1 myocardial infarction (T1MI). Therefor...
Takotsubo syndrome: Comparison of data from the 2024 world literature and the 2016-2018 InterTak registry subgroup [0.03%]
tako氏综合征：2024年世界文献数据与2016-2018年InterTak注册登记亚组的数据对比
John E Madias
John E Madias
A comparison of data on patients with takotsubo syndrome (TTS), from the World literature (WL) 2024 with the InterTalk 2016-2018 registry subgroup showed a much younger population of patients suffering TTS triggered by physical stresses, wi...
Evolving Paradigms in Cardiovascular Pharmacology: Advances and Clinical Significance [0.03%]
心血管药理学的发展范式：进展与临床意义
Riya Pandey,Pratichi Singh
Riya Pandey
Cardiovascular disease is the leading cause of morbidity and mortality among both the elderly and the young, making cardiovascular drugs the most commonly prescribed medications for these populations. Cardiovascular conditions such as arrhy...
Psychopharmacological Treatment of Patients with Heart Failure: A Narrative Review of Antidepressants and Anxiolytics [0.03%]
心力衰竭患者的心理药物治疗：抗抑郁药和镇静催眠药的叙述性综述
Błażej Pilarski,Alexander Suchodolski,Szymon Florek et al.
Błażej Pilarski et al.
Heart failure (HF) commonly coexists with psychiatric disorders, particularly depression and anxiety, which significantly worsen prognosis and complicate treatment. Approximately 25 million Europeans suffer from anxiety disorders and 21 mil...
Clinical Outcomes in Patients With Hypertension and Renal Artery Stenosis Across Age Categories [0.03%]
不同年龄段高血压肾动脉狭窄患者的临床转归分析
Amith Seri,Bilal Hussain,Vikas Aggarwal et al.
Amith Seri et al.
Introduction: Renal artery stenosis (RAS) is a common cause of secondary hypertension (HTN) and chronic kidney disease (CKD). Studies have suggested that the prevalence of RAS increases with age. Data comparing the outcom...
Lipid-lowering therapy in acute coronary syndrome: Limitations of the stepwise approach and rationale for a 'strike early, strike strong' strategy [0.03%]
急性冠脉综合征降脂治疗：逐步达标方案的局限性及早期强化治疗策略的必要性
Benjamin Rossi,Walter Masson
Benjamin Rossi
Acute coronary syndrome (ACS) is associated with a markedly increased risk of recurrent cardiovascular events, particularly during the early post-event period, which is characterized by persistent inflammation, endothelial dysfunction, plaq...
Determinants of cardiorespiratory fitness after successfully reperfused ST-elevation myocardial infarction [0.03%]
成功再灌注的ST段抬高型心肌梗死后影响 cardiopulmonary Fitness 的决定因素
Austin C Hogwood,Krzysztof Smarż,Michele Golino et al.
Austin C Hogwood et al.
Background: Modern treatment of ST-elevation myocardial infarction (STEMI), emphasizing prompt reperfusion, has improved clinical outcomes by preserving cardiac function. Despite this, cardiorespiratory fitness remains im...
Multimodal Artificial Intelligence for Early Detection and Precision Management of Inflammatory and Infiltrative Cardiomyopathies [0.03%]
多模态人工智能在炎症性及浸润性心肌病的早期检测和精准管理中的应用
Parth Adrejiya,Deya A Alkhatib,Wael Aljaroudi
Parth Adrejiya
Background: Inflammatory and infiltrative cardiomyopathies, including cardiac sarcoidosis, transthyretin amyloidosis, and autoimmune myocarditis, are frequently underrecognized until advanced myocardial dysfunction develo...
Comparative efficacy of baroreflex activation therapy, cardiac contractility modulation, and cardiac resynchronization therapy in heart failure with reduced ejection fraction: a systematic review and network meta-analysis of randomized controlled trials [0.03%]
心力衰竭射血分数降低患者中，心脏收缩力调制、巴反射激活和心脏再同步化治疗的比较有效性的系统评价和网络 meta 分析
Indranill Basu-Ray,Roy Arokiam Daniel,Sandeep Ajoy Saha et al.
Indranill Basu-Ray et al.
Background: Heart failure with reduced ejection fraction (HFrEF) remains a major global health burden despite advances in guideline-directed medical therapy (GDMT). Device-based therapies-including baroreflex activation t...
Obesity and cardiovascular risk in down syndrome: Challenges and updated management [0.03%]
唐氏综合征的肥胖和心血管风险：挑战与最新管理方法
Aditya Lumb,Brayden Levillard,Vitória Rios et al.
Aditya Lumb et al.
Down syndrome (DS) or trisomy 21 is a genetic condition presenting with intellectual disabilities, distinctive phenotypic features, and multisystem involvement. As life expectancy in individuals with DS increases, obesity has emerged as a s...